An economic evaluation of screening for Chlamydia trachomatis in adolescent males

GENÇ, Mustafa

doi:10.1001/jama.270.17.2057

Cited by 31 publications

(29 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…25,[194][195][196][197][198][199][200][201][202][203][204][205][206] The majority of these papers concluded that this type of screening was cost-effective. The majority of these studies (12/14) used static modelling approaches that were judged to be inappropriate for making policy recommendations.…”

Section: Studies Of Chlamydia Screening Interventionsmentioning

confidence: 99%

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection

Low

McCarthy²,

Macleod³

et al. 2007

Health Technol Assess

134

179

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment ProgrammeT he Health Technology Assessment (HTA) programme, now part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the costs, effectiveness and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care. The research findings from the HTA Programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA Programme is needs-led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research are actively sought from people working in the NHS, the public and consumer groups and professional bodies such as r...

show abstract

Section: Studies Of Chlamydia Screening Interventionsmentioning

confidence: 99%

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection

Low

McCarthy²,

Macleod³

et al. 2007

Health Technol Assess

134

179

View full text Add to dashboard Cite

show abstract

“…Projections about the costs and benefits of clinic-based CT-screening programs take into account the fact that many patients who test positive for this infection are never notified of their test results or treated, and even fewer notify their sexual partners. 17,29,32,64,[109][110][111][112][113][114][115][116][117][118][119][120][121][122] However, absent information about the follow-up of asymptomatic patients who test positive for CT on specimens they collect at home or they or their care providers collect in other non-clinic settings, findings about the efficacy of screening clinic populations cannot be extrapolated to non-clinic populations. 17 While such inferences are inappropriate, given the failure of current screening strategies to control this easily curable STD, 6 the data are sufficiently compelling to make further study of the factors that motivate asymptomatic individuals to seek STD testing and ways to help them overcome the numerous barriers they encounter if and when they decide to do so a matter of intense public health interest.…”

Section: And M 6: Lower Genital Tract Chlamydial Infection Is a Clinimentioning

confidence: 99%

“…2 Determining how frequently individuals must be screened to lower the prevalence of chlamydial infections and CT-related morbidity at the population level is an even more complex task. [1][2][3][4][5][6][7][8][9]17,27,64,[116][117][118][119][120][121][122][123][124] Mathematical models demonstrate two important facts about the process. [114][115][116] First, screening programs must run for a period of time to significantly lower the incidence of CT at the population level.…”

Section: And M 6: Lower Genital Tract Chlamydial Infection Is a Clinimentioning

confidence: 99%

Chlamydia Trachomatis: Common Misperceptions and Misunderstandings

Stevens‐Simon

Sheeder

2005

Journal of Pediatric and Adolescent Gynecology

View full text Add to dashboard Cite

“…A Swedish study (Genc, Ruusuvaara, & Mardh, 1993) found that routine screening of high-risk adolescents for chlamydia in a primary care setting was cost-effective if prevalence was above 2% for chlamydia.…”

Section: Sexually Transmitted Diseases and Tuberculosismentioning

confidence: 99%

What Is Known About the Cost-Effectiveness of Health Services for Returning Prisoners?

Howell

Greifinger²,

Sommers

2004

Journal of Correctional Health Care

View full text Add to dashboard Cite

This literature review on the cost-effectiveness of health services for returning prisoners focuses on studies related to screening and treatment for five conditions disproportionately prevalent among returning prisoners: HIV, sexually transmitted diseases, tuberculosis, mental illness, and substance abuse. Research suggests that programs addressing all of these conditions are cost-effective. However, there are not enough well-designed studies that include returning prisoners or very similar populations to draw definite conclusions. More research is needed to assess the impacts of such on returning prisoners. Community coalitions are needed to generate financial support and negotiate the allocation of programs across governmental sectors for this population.

show abstract

An economic evaluation of screening for Chlamydia trachomatis in adolescent males

Cited by 31 publications

References 0 publications

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection

Chlamydia Trachomatis: Common Misperceptions and Misunderstandings

What Is Known About the Cost-Effectiveness of Health Services for Returning Prisoners?

Contact Info

Product

Resources

About